Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma.

[1]  D. Margolskee,et al.  Urinary LTE4 excretion in antigen‐provoked asthmatic patients treated with the inhaled LTD4 antagonist, L‐648,051 , 1992, Allergy.

[2]  P. Tagari,et al.  Reduced nonspecific bronchial reactivity and decreased airway response to antigen challenge in atopic asthmatic patients treated with the inhaled leukotriene D4 antagonist, L‐648,051 , 1992, Allergy.

[3]  K. Andersson,et al.  Reversal and prevention of airway response to antigen challenge by the inhaled leukotriene D4 antagonist (L‐648, 051) in patients with atopic asthma , 1991, Allergy.

[4]  W. Abraham,et al.  Separation of late bronchial responses from airway hyperresponsiveness in allergic sheep. , 1991, Journal of applied physiology.

[5]  J. Hsieh,et al.  Interspecies differences in stereoselective protein binding and clearance of MK-571. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[6]  R. Krell,et al.  An examination of the influence of the epithelium on contractile responses to peptidoleukotrienes and blockade by ICI 204,219 in isolated guinea pig trachea and human intralobar airways. , 1990, The Journal of pharmacology and experimental therapeutics.

[7]  C. Dollery,et al.  Leukotriene C4 elimination and metabolism in man. , 1990, The Journal of allergy and clinical immunology.

[8]  C T Dollery,et al.  Effect of the oral leukotriene D4 antagonist LY171883 on inhaled and intradermal challenge with antigen and leukotriene D4 in atopic subjects. , 1989, The Journal of allergy and clinical immunology.

[9]  C. Dollery,et al.  URINARY LEUKOTRIENE E4 AFTER ANTIGEN CHALLENGE AND IN ACUTE ASTHMA AND ALLERGIC RHINITIS , 1989, The Lancet.

[10]  S. Charleson,et al.  Measurement of urinary leukotrienes by reversed-phase liquid chromatography and radioimmunoassay. , 1989, Clinical chemistry.

[11]  A. Ford-hutchinson,et al.  Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. , 1989, Canadian journal of physiology and pharmacology.

[12]  S. Dahlén,et al.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. , 1987, Science.

[13]  S P Hanley,et al.  The effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma. , 1987, The Journal of allergy and clinical immunology.

[14]  D. Coursin,et al.  Pharmacological evidence that human intralobar airways do not contain different receptors that mediate contractions to leukotriene C4 and leukotriene D4. , 1986, The Journal of pharmacology and experimental therapeutics.

[15]  R. Vessella,et al.  Identification and characterization of leukotriene D4 receptors in adult and fetal human lung. , 1985, Biochemical pharmacology.

[16]  R. Patterson,et al.  The effect of inhaled leukotriene D4 in humans. , 1985, The American review of respiratory disease.

[17]  H. Wu,et al.  Identification of leukotriene D4 specific binding sites in the membrane preparation isolated from guinea pig lung. , 1984, Prostaglandins.

[18]  N. Barnes,et al.  Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects. , 1984, Thorax.

[19]  E. R. Mcfadden,et al.  Airway constriction in normal humans produced by inhalation of leukotriene D. Potency, time course, and effect of aspirin therapy. , 1983, JAMA.

[20]  S. Dahlén,et al.  Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Shelhamer,et al.  Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. , 2015, The American review of respiratory disease.

[22]  P. Sen,et al.  Introduction to bivariate and multivariate analysis , 1981 .

[23]  S. Dahlén,et al.  Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Bengt Samuelsson,et al.  Leukotrienes are potent constrictors of human bronchi , 1980, Nature.

[25]  F. Hargreave,et al.  Factors in allergen‐induced asthma: relevance of the intensity of the airways allergic reaction and non‐specific bronchial reactivity , 1976, Clinical allergy.

[26]  J. Grizzle.  THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS. , 1965, Biometrics.

[27]  Seymour Geisser,et al.  Statistical Principles in Experimental Design , 1963 .